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Abstract
Background: High mammographic density is a strong, well-established breast cancer risk factor. Three studies
conducted in various smaller geographic settings reported inconsistent findings between air pollution and
mammographic density. We assessed whether particulate matter (PM) exposures (PM2.5, PM2.5–10, and PM10) and
distance to roadways were associated with mammographic density among women residing across the United States.
Methods: The Nurses’ Health Studies are prospective cohorts for whom a subset has screening mammograms from
the 1990s (interquartile range 1990–1999). PM was estimated using spatio-temporal models linked to residential
addresses. Among 3258 women (average age at mammogram 52.7 years), we performed multivariable linear
regression to assess associations between square-root-transformed mammographic density and PM within 1 and 3
years before the mammogram. For linear regression estimates of PM in relation to untransformed mammographic
density outcomes, bootstrapped robust standard errors are used to calculate 95% confidence intervals (CIs). Analyses
were stratified by menopausal status and region of residence.
Results: Recent PM and distance to roadways were not associated with mammographic density in premenopausal
women (PM2.5 within 3 years before mammogram β = 0.05, 95% CI –0.16, 0.27; PM2.5–10 β = 0, 95%, CI –0.15, 0.16; PM10
β = 0.02, 95% CI –0.10, 0.13) and postmenopausal women (PM2.5 within 3 years before mammogram β = –0.05, 95% CI
–0.27, 0.17; PM2.5–10 β = –0.01, 95% CI –0.16, 0.14; PM10 β = –0.02, 95% CI –0.13, 0.09). Largely null associations were
observed within regions. Suggestive associations were observed among postmenopausal women in the Northeast (n
= 745), where a 10-μg/m3 increase in PM2.5 within 3 years before the mammogram was associated with 3.4 percentage
points higher percent mammographic density (95% CI –0.5, 7.3).
Conclusions: These findings do not support that recent PM or roadway exposures influence mammographic density.
Although PM was largely not associated with mammographic density, we cannot rule out the role of PM during earlier
exposure time windows and possible associations among northeastern postmenopausal women.
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Background
In 2013, 66.8% of women in the United States aged ≥ 40
years had undergone a mammogram within the previous 2
years [1]. Mammograms not only aid in breast tumor de-
tection but also provide a radiographic image of the breast
that distinguishes fat and fibroglandular tissue based on
their differences in X-ray absorption. The fat tissue in the
breast is radiolucent and appears dark on the mammogram,
while the dense stromal and epithelial tissue is radiopaque
and appears bright. The proportion of dense tissue area
compared to the total breast tissue area yields a measure of
percent breast density, which is an established breast cancer
risk factor. In a meta-analysis, compared to women with
less than 5% dense tissue on a mammogram, women with
50–74% dense tissue had a 3.0-fold increased risk of devel-
oping breast cancer and women with ≥ 75% dense tissue
had a 4.6-fold increased risk [2]. Percent mammographic
density was reported to be an intermediate marker of breast
cancer risk for certain exposures, such as early life body size
and hormonal therapy use, although not all breast cancer
risk factors are mediated by mammographic density [3].
Therefore, identifying predictors of breast density variation
may be important for breast cancer risk reduction and is
becoming increasingly relevant in the United States as
more than half of the states mandate that physicians notify
women who have dense breasts. While many studies of
breast density highlight the relevance of age, hormonal, and
reproductive factors [4], limited research investigates the
role of air pollutants that can bind to estrogen receptors to
induce hormonal changes via endocrine disruption [5, 6].
The World Health Organization’s International Agency
for Research on Cancer classified ambient air pollution and
particulate matter (PM) as Group 1 human carcinogens
largely based on results from lung cancer studies [7]. How-
ever, studies of air pollution metrics and risk of breast can-
cer have produced inconsistent results [8–16] and have
been largely null for recent PM exposures in cohort studies
[17–19], but this does not rule out whether PM in early
time windows of exposure influences disease incidence or
whether PM influences earlier changes in the breast. In
2012, the Institute of Medicine issued a report calling on
breast cancer research to address early mechanisms of
breast carcinogenesis as well as the influence of environ-
mental exposures and pollutants across the life course [20];
studying the associations of pollutants and mammographic
density variation can provide insight into early breast tissue
variation that may translate to breast cancer risk reduction
strategies. To date, three studies conducted in smaller geo-
graphic settings within Europe and the United States
assessed associations between air pollution metrics and
mammographic density measures but reported inconsistent
findings [21–23], likely due to differences and limitations in
PM measurement methods and the use of categorical mea-
sures of mammographic density.
Given the large geographical scope of the nationwide US-
based Nurses’ Health Study (NHS) and NHSII cohorts and
the ability to control for well-established breast cancer risk
factors and predictors of mammographic density, we inves-
tigated associations between PM exposures at one’s residen-
tial address and distance to roadways in relation to a
continuous measure of mammographic density in women
without breast cancer. We assessed the associations separ-
ately for premenopausal and postmenopausal women and
within regions of the United States.
Methods
Study population
The NHS cohort was established in 1976, enrolling 121,700
married, female US nurses between the ages of 30 and 55
years who resided in 11 states at entry (California, Con-
necticut, Florida, Massachusetts, Maryland, Michigan, New
Jersey, New York, Ohio, Pennsylvania, and Texas) [24]. The
NHSII cohort was established in 1989, enrolling 116,430 fe-
male US nurses between the ages of 25 and 42 years resid-
ing in 14 states (California, Connecticut, Indiana, Iowa,
Kentucky, Massachusetts, Michigan, Missouri, New York,
North Carolina, Ohio, Pennsylvania, South Carolina, and
Texas). Briefly, participants in both cohorts completed base-
line and subsequent biennial questionnaires on medical his-
tory and covariate data (e.g., anthropometrics, reproductive
history, and lifestyle factors) that were mailed to their resi-
dential addresses. Participants reported breast cancer diag-
noses on biennial questionnaires and the diagnoses were
confirmed by review of medical records. In 1989–1990 and
1996–1999 a subset of participants from the NHS and the
NHSII, respectively, provided blood samples, and breast
cancer case–control studies nested within the NHS (cases
n = 5371, controls n = 7469) and the NHSII (cases n = 2750,
controls n = 5500) were established to evaluate blood-based
biomarkers of risk. Around the time of blood draw, the ma-
jority of the NHS (80.1%) and NHSII (89.2%) participants
reported having a mammogram in the last 2 years on the
1990 and 1999 questionnaires, respectively. Film mammo-
grams were collected from women who were participants in
the nested breast cancer case–control studies and who also
reported mammography around the time of blood collec-
tion. We successfully obtained mammograms from approxi-
mately 80% of the eligible participants from the NHS (cases
n = 1304, controls n = 2362) and the NHSII (cases n = 758,
controls n = 1833) [25, 26]. These mammograms were pri-
marily conducted in the early 1990s for the NHS (interquar-
tile range (IQR) 1990–1994) and in the late 1990s for the
NHSII (IQR 1997–2000). For this study, we used only
mammograms from the controls that were reported as
screening mammograms; mammograms for diagnostic pur-
poses and those from breast cancer cases were excluded.
Among the controls, women with and without collected
mammograms were similar with regards to breast cancer
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risk factors such as age, body mass index, parity, and family
history of breast cancer [25, 26].
Outcomes: mammographic density measures
Film mammograms of the cranio-caudal views of each
breast were digitized with a Lumysis 85 laser film scanner
for all NHS mammograms and for the first two batches of
NHSII mammograms, and with a VIDAR CAD PRO Ad-
vantage scanner (VIDAR Systems Corporation, Herndon,
VA, USA) for the third batch of NHSII mammograms. The
correlation between percent density measures from the two
scanners was 0.88 [27]. Trained observers were blinded to
exposure status and used a computer-assisted thresholding
method (Cumulus software) to measure mammographic
density. Breast density measurements were averaged across
both breasts. Replicate mammograms from each batch of
density readings exhibited high within-person intraclass
correlation coefficients ≥ 0.90 [28]. Despite these high
within-person intraclass correlation coefficients, between-
batch variability was present in the NHSII. Batch adjust-
ment methods were applied to the second and third NHSII
batch measurements to reflect the density measurements
had they been evaluated in the first batch [26, 29]. The pri-
mary outcome of interest was percent mammographic
density (i.e., the dense area divided by the total breast area),
and secondary outcomes of interest included absolute
dense area (cm2) and absolute nondense area (cm2).
Exposures: particulate matter and proximity to roadways
Residential addresses were updated biennially in both the
NHS and the NHSII as part of the questionnaire mailing
process. By the mid-1990s, participants resided in all 50
states [30]. Study participants’ residential addresses were
geocoded and linked to predicted estimates of PM and to
proximity to various-sized roadways over the course of
the study.
i. Particulate matter
In the current study, the primary exposures of
interest were PM levels 1 year before the year of the
mammogram and the cumulative average PM for up
to 3 years prior to the mammogram year. Particulate
matter is classified into three size fractions,
including fine particles less than 2.5 μm in
aerodynamic diameter (PM2.5), thoracic particles less
than 10 μm (PM10), and coarse particles between 2.5
and 10 μm (PM2.5–10). Particulate matter comes
from various sources and the varying contribution of
these sources is different in each region of the
United States. These sources generally include motor
vehicle emissions, tire fragments, road dust,
industrial and agricultural combustion, wood
burning, pollens and molds, forest fires, volcanic
emissions, and sea spray [31]. We defined the
regions of the United States based on the Census
Bureau designated regions [32]: Northeast (CT, ME,
MA, NH, NJ, NY, PA, RI, and VT), Midwest (IL, IN,
IA, KS, MI, MN, MO, NE, ND, OH, SD, and WI),
South (AL, AR, DE, DC, FL, GA, KY, LA, MD, MS,
NC, OK, SC, TN, TX, VA, and WV), and West (AZ,
CA, CO, ID, MT, NV, NM, OR, UT, WA, and WY).
Briefly, predictions of ambient PM were available
across the 48 conterminous United States (i.e., all
states excluding Alaska and Hawaii). Predictions of
monthly average PM2.5 and PM10 were generated
using geographic information system (GIS)-based
spatio-temporal models to account for spatial and
meteorological variation over time [33]. The monthly
estimates were linked with participants’ residential
addresses between 1988 and 2007 [33]. PM2.5 data
were not directly measured before 1999, and there-
fore we derived PM2.5 levels before 1999 from the
PM10 levels before 1999 using the 1999 ratio of
PM2.5:PM10 [33]. Coarse particulate matter (PM2.5–
10) was calculated as the difference between PM10
and PM2.5 estimates. The models were evaluated for
predictive accuracy using a 10-set cross-validation
approach; cross-validation correlation coefficients
were high for PM2.5 (R
2 = 0.77) and moderate for
PM10 (R
2 = 0.58) and PM2.5–10 (R
2 = 0.46) [33].
ii. Proximity to roadways
Secondary exposures of interest included proximity
between one’s residential address in the year before
the mammogram to various types of major roadways
as a proxy for traffic-related exposures. For women
with a street-segment level geocoded address, prox-
imity of residential address to nearest roadways was
calculated in meters using GIS software and the
ESRI StreetMap Pro 2007 road network data. Dis-
tances to three different types of roadways were clas-
sified based on the US Census Feature Class Code
road classification system. The types of roadways in-
cluded: A1 (primary roads, typically interstate high-
ways, with limited access, division between opposing
directions of traffic, and defined exits), A2 (primary
major, noninterstate highways and major roads with-
out access restrictions), and A3 (smaller, secondary
roads, usually with more than two lanes).
Study sample
To study the influence of PM and proximity to road on
normal breast tissue composition, we restricted the ana-
lyses to NHS and NHSII participants without breast can-
cer for whom mammographic density data were
available (i.e., controls within the original nested case–
control studies; n = 2362 for NHS, n = 1833 for NHSII).
Our analyses were further restricted to women who had
a screening film mammogram dated between January
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1990 and December 2008 and those with data available
on estimated PM exposures living in the conterminous
United States (n = 1821 for NHS, n = 1815 for NHSII).
Because menopause status and BMI are the strongest
predictors of mammographic density, we excluded
women with missing or dubious menopause status (n =
308) or with missing BMI data (n = 70) at the time of
mammogram. The final study sample comprised 3258
participants (n = 1624 premenopausal women; n = 1634
postmenopausal women).
Covariates
We considered the following variables in the multivariable-
adjusted models: cohort/batch (NHS first batch, NHS sec-
ond batch, NHSII), age at mammogram (years), BMI at
mammogram (kg/m2), categories of parity and age at first
birth (nulliparous, 1–4 children and age at first birth < 25
years, 1–4 children and age at first birth 25–29 years, 1–4
children and age at first birth ≥ 30 years, ≥ 5 children, miss-
ing), categories of hormonal therapy use (never, current,
past, missing), history of biopsy-confirmed benign breast
disease, age at menopause (for postmenopausal women
only), categories of breast feeding status (nulliparous, never
breast fed, ever breast fed, missing), age at menarche
(years), oral contraceptive use among premenopausal
women only (not on oral contraceptives, current for < 5
years, current for 5 + years, missing), family history of
breast cancer, race/ethnicity (White, Black, Hispanic,
Other), BMI at age 18 (<19 kg/m2, 19–24.9 kg/m2, 25–29.9
kg/m2, ≥ 30 kg/m2, missing), alcohol consumption (g/day),
physical activity (MET hours/week), Census tract-level me-
dian house value and median income based on values from
the 2000 Census, region of residence (Northeast, Midwest,
West, South), and date of mammogram to account for the
strong decreasing trends in PM levels over time.
Statistical analyses
Analyses were carried out separately for women who were
premenopausal and postmenopausal at the time of the
mammogram. Mammographic density measures were
square-root transformed to achieve the statistical assump-
tions for linear regression. Multivariable linear regression
was conducted to estimate the average difference in
square-root-transformed breast density measures for a 10-
μg/m3 increase of PM2.5, PM2.5–10, and PM10 and to
compare previously published categories of residential
proximity to A1, A1–A2, and A1–A3 roadways (< 50 me-
ters, 50–199 meters, and ≥ 200 meters as the referent
group) [30]. In the final multivariable models for premen-
opausal and postmenopausal women, we included the
strongest predictors of mammographic density including
cohort/batch, age at mammogram, BMI at mammogram,
parity and age at first birth categories, hormonal therapy
use, and history of biopsy-confirmed benign breast
disease. In sensitivity analyses, we additionally considered
other aforementioned covariates. When we present the
linear regression estimates for the untransformed mam-
mographic density outcome measures as the dependent
variable, bootstrapped robust standard errors are used to
calculate 95% confidence intervals (CIs).
We used the likelihood ratio test (LRT) to determine
whether the associations between the exposures and per-
cent density varied by cohort and by region of residence.
In addition to the PM results presented across the entire
United States, estimates from multivariable models were
presented separately for each region. We used nonpara-
metric restricted cubic regression splines [34] to deter-
mine whether the associations between PM and percent
mammographic density were nonlinear. In sensitivity ana-
lyses, we additionally restricted the sample to women who
did not move to another state before their mammogram.
All analyses were conducted in SAS version 9.4 (SAS,
Cary, NC, USA).
Results
The 1989 median level of PM2.5 was 16.9 μg/m
3 (IQR
14.4, 19.5), of PM2.5–10 was 10.6 μg/m
3 (IQR 8.1, 14.2),
and of PM10 was 27.7 μg/m
3 (IQR 23.8, 32.2). The high-
est median PM2.5 level was in the Midwest (18.5 μg/m
3,
IQR 16.2, 20.5) followed by the Northeast (16.6 μg/m3,
IQR 14.7, 18.9), the West (15.5 μg/m3, IQR 13.4, 20.8),
and the South (13.0 μg/m3, IQR 11.0, 17.8). The highest
median PM2.5–10 level was in the West (19.6 μg/m
3, IQR
16.4, 25.3) followed by the South (12.4 μg/m3, IQR 10.8,
13.9), the Midwest (10.8 μg/m3, IQR 8.3, 14.3), and the
Northeast (8.6 μg/m3, IQR 7.1, 10.3). There were no sta-
tistically significant interactions with PM exposures and
cohort for the multivariable models among premeno-
pausal or among postmenopausal women (LRT p > 0.15).
Premenopausal women
Premenopausal women (n = 1624) in the highest year-
adjusted quintiles of PM2.5 1 year before the mammo-
gram were more likely to be overweight/obese at age 18,
to have never breast fed, to be current oral contraceptive
users, and were less likely to have a history of benign
breast disease or family history of breast cancer com-
pared to women in the lowest quintile (Table 1).
Among premenopausal women residing across the
United States, no associations were observed between PM
exposures and percent mammographic density (Table 2),
dense area, or nondense area (see Additional file 1) after
multivariable adjustment. The patterns of association be-
tween PM and percent density were similar after further
adjustment for other covariates and after restricting to
women who did not move to another state before the
mammogram. The associations were null and not statisti-
cally significant comparing premenopausal women who live
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Table 1 Age-standardized characteristics by calendar-year-adjusted PM2.5 quintiles in premenopausal (n = 1624) and postmenopausal
(n = 1634) participants









Age at mammogramb 45.6 ± 4.2 45.6 ± 4.3 60.0 ± 7.4 59.7 ± 7.6
NHSII cohort (%) 76 78 19 24
BMI at mammogram (kg/m2) 25.1 ± 5.6 25.8 ± 5.5 26.1 ± 5.0 26.5 ± 5.6
Presence of biopsy-confirmed benign breast disease (%) 18.8 17.8 23.4 21.8
Current use of hormonal therapy (%) 2.7 2.3 52.2 47.3
Parity and age at first birth status (%)
Nulliparous 16.3 16.5 9.8 9.8
1–4 children before age 25 29.0 29.3 36.5 38.2
1–4 children between age 25 and 30 33.8 34.4 31.9 29.5
1–4 children after age 30 17.7 17.0 8.6 9.8
5+ children 2.6 1.9 12.6 11.7
Missing 0.6 0.9 0.5 1.0
Categories of BMI at age 18 (%)
< 19.0 kg/m2 16.0 17.8 10.6 13.3
19.0–24.9 kg/m2 72.2 70.7 75.6 72.9
25–29.9 kg/m2 7.4 8.5 9.4 8.1
30+ kg/m2 1.9 1.7 0.9 1.9
Missing 2.5 1.3 3.5 3.8
Family history of breast cancer (%) 10.7 8.5 13.0 11.0
Age at menarche (years) 12.4 ± 1.4 12.4 ± 1.4 12.4 ± 1.3 12.6 ± 1.5
Lactation among parous women (%)
Never breastfed 15.0 21.9 35.8 41.5
Yes‚ breastfed > 1 month 82.5 75.1 62.8 57.0
Missing 2.5 3.1 1.5 1.3
Oral contraceptive use (%)
Not on oral contraceptives 94.4 93.4 – –
Current < 5 years 2.6 1.5 – –
Current 5 + years 2.7 4.9 – –
Missing 0.3 0.3 – –
Alcohol consumption (g/day) 5.3 ± 8.4 3.8 ± 6.3 5.6 ± 9.1 4.8 ± 8.1
Physical activity (MET hours/week) 22.2 ± 29.6 17.5 ± 19.2 17.6 ± 17.3 19.4 ± 26.3
White (%) 99.4 97.5 98.6 97.7
Region of residence (%)
Northeast 27.8 27.4 28.0 33.4
Midwest 13.8 40.5 6.5 34.8
West 39.4 16.5 33.8 20.6
South 18.9 15.6 31.7 11.2
Distance from residential address to A1–A3 roadways (meters) 313.8 ± 185.9 231.1 ± 169.6 299.0 ± 187.5 220.2 ± 168.1
PM2.5 particulate matter less than 2.5 μm in diameter, NHSII Nurses’ Health Study II, BMI body mass index, MET metabolic equivalent
aValues are mean ± SD or percentages and are standardized to the age distribution of the study population. Values of polytomous variables may not sum to 100%
due to rounding
bValue is not age adjusted
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closer to roadways to those who live further away (Table 3).
There was no evidence for a nonlinear relationship between
PM and percent mammographic density.
Postmenopausal women
Postmenopausal women (n = 1634) in the highest year-
adjusted quintiles of PM2.5 1 year before the mammo-
gram were similar in terms of most mammographic
density predictors compared to women in the lowest
quintile (Table 1). However, women in the highest quin-
tile were more likely to have never used hormonal ther-
apy or lactated and were less likely to have had a history
of benign breast disease and family history of breast can-
cer compared to women in the lowest quintile.
There were no associations between PM exposures or
proximity to roadways and mammographic density out-
comes for postmenopausal women overall (Tables 2 and 3;
see Additional file 1: Table S1 for dense and nondense area
outcomes). We did observe borderline statistically signifi-
cant interactions between region and PM2.5 and PM10 levels
with percent density (Table 2, p for interaction with region
< 0.10). Among postmenopausal women in the Midwest
and the South, the results were null and not statistically sig-
nificant for PM exposures and density measures (Table 2;
see Additional file 1: Table S1 for dense and nondense area
outcomes).
Among postmenopausal women in the West, there were
no statistically significant associations between PM2.5 and
transformed mammographic density measures; however,
suggestive inverse associations were observed for PM2.5–10
with percent density (β = –0.23, 95% CI –0.47, 0.02;
Table 2), although the p value for interaction between
PM2.5–10 and region was not statistically significant (p for
interaction = 0.24). For the estimates of untransformed
percent mammographic density, a 10-μg/m3 increase in
cumulative PM2.5–10 up to 3 years before the mammo-
gram was associated with an average difference of –2.0
percentage points (95% CI –4.7, 0.6; Additional file 1:
Table S2). The patterns of association for postmenopausal
PM results in the West did not change meaningfully after
additional adjustment of other covariates or after restrict-
ing to nonmovers.
In contrast among postmenopausal women in the North-
east, there were no statistically significant associations be-
tween PM2.5–10 and transformed mammographic density
measures (Table 2; see Additional file 1: Table S1 for dense
and nondense area measures); however, there were suggest-
ive positive associations between PM2.5 and transformed
percent mammographic density (β = 0.39, 95% CI –0.02,
Table 2 Estimated differencesa (95% confidence interval) in square-root-transformed percent mammographic density for a 10-μg/m3
PM increase
Across the United States Northeast Midwest West South p for region
interaction term
Premenopausal
1 year prior n = 1624 n = 577 n = 554 n = 261 n = 232
PM2.5 0.04 (–0.17, 0.26) 0.06 (–0.40, 0.52) –0.08 (–0.58, 0.43) 0 (–0.35, 0.34) 0.21 (–0.32, 0.74) 0.59
PM2.5–10 –0.01 (–0.16, 0.15) –0.01 (–0.57, 0.54) –0.07 (–0.42, 0.28) 0.08 (–0.19, 0.34) –0.34 (–0.95, 0.27) 0.45
PM10 0.01 (–0.10, 0.12) 0.02 (–0.26, 0.30) –0.06 (–0.33, 0.20) 0.03 (–0.14, 0.20) –0.05 (–0.57, 0.47) 0.58
3-year average n = 1624 n = 582 n = 554 n = 260 n = 228
PM2.5 0.05 (–0.16, 0.27) 0.05 (–0.40, 0.51) –0.05 (–0.55, 0.45) –0.01 (–0.36, 0.35) 0.27 (–0.27, 0.81) 0.53
PM2.5–10 0 (–0.15, 0.16) 0.02 (–0.53, 0.57) –0.04 (–0.40, 0.33) 0.10 (–0.18, 0.38) –0.58 (–1.19, 0.03) 0.22
PM10 0.02 (–0.10, 0.13) 0.02 (–0.25, 0.30) –0.03 (–0.30, 0.23) 0.04 (–0.13, 0.20) –0.17 (–0.70, 0.36) 0.67
Postmenopausal
1 year prior n = 1634 n = 738 n = 360 n = 274 n = 262
PM2.5 –0.04 (–0.26, 0.19) 0.37 (–0.03, 0.77) –0.24 (–0.91, 0.42) –0.21 (–0.56, 0.13) –0.05 (–0.70, 0.60) 0.09
PM2.5–10 –0.01 (–0.16, 0.14) 0.22 (–0.24, 0.69) 0.11 (–0.38, 0.60) –0.22 (–0.47, 0.03) 0.32 (–0.32, 0.96) 0.29
PM10 –0.01 (–0.12, 0.10) 0.19 (–0.05, 0.42) –0.01 (–0.34, 0.32) –0.14 (–0.29, 0.02) 0.19 (–0.35, 0.74) 0.15
3-year average n = 1634 n = 745 n = 364 n = 272 n = 253
PM2.5 –0.05 (–0.27, 0.17) 0.39 (–0.02, 0.79) –0.25 (–0.91, 0.42) –0.27 (–0.62, 0.07) 0.06 (–0.61, 0.73) 0.06
PM2.5–10 –0.01 (–0.16, 0.14) 0.19 (–0.27, 0.65) 0.16 (–0.32, 0.64) –0.23 (–0.47, 0.02) 0.39 (–0.30, 1.07) 0.24
PM10 –0.02 (–0.13, 0.09) 0.18 (–0.06, 0.41) 0.02 (–0.31, 0.34) –0.15 (–0.31, 0.01) 0.31 (–0.26, 0.89) 0.10
PM particulate matter, PM2.5 particulate matter less than 2.5 μm in diameter, PM2.5–10 particulate matter between 2.5 and 10 μm in diameter, PM10 particulate
matter less than 10 μm in diameter
aAdjusted for cohort, age, body mass index, parity and age at first birth categories, hormonal therapy use, history of biopsy-confirmed benign breast disease, and
date of mammogram
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0.79; Table 2) and significant inverse associations with
transformed nondense area (β =–0.76, 95% CI –1.41, –
0.11; see Additional file 1: Table S1). For the estimates of
untransformed mammographic density measures, a 10-μg/
m3 increase in 3-year cumulative PM2.5 in the Northeast
was associated with an average difference in percent mam-
mographic density of 3.4 percentage points (95% CI –0.5,
7.3; Additional file 1: Table S2) and an average difference in
nondense area of –17.2 cm2 (95% CI –36.1, –0.5; Add-
itional file 1: Table S2). The associations did not change
meaningfully after further adjustment for other covariates
or after restricting to nonmovers. There was no evidence
for a nonlinear relationship between PM and percent mam-
mographic density.
Discussion
In summary, we observed no overall association between
residential PM exposures or proximity to roadways and
mammographic density in premenopausal and postmeno-
pausal women residing across the conterminous United
States. This is consistent with the reported null overall as-
sociations between PM and breast cancer incidence in pro-
spective cohort studies from the Danish Nurse Cohort, the
NHSII, and the Sister Study Cohort [17–19]. Upon further
exploration, we did observe differences in associations with
PM exposures and mammographic density by region of the
United States among postmenopausal women. Recent ex-
posure to fine particulate matter (PM2.5) in the Northeast
was associated with a percent mammographic density 3.4
percentage points higher percent mammographic density
(95% CI –0.5, 7.3) among postmenopausal women.
Unexpectedly, recent coarse particulate matter (PM2.5–10)
in the West showed a weaker, inverse association with per-
cent density (–2.0 percentage point difference, 95% CI –4.7,
0.6).
Three studies based in Denmark, in the Netherlands,
and in five registries in the US Breast Cancer Surveillance
Consortium (New Hampshire, Vermont, New Mexico, San
Francisco, and western Washington) reported inconsistent
findings between air pollution exposures and mammo-
graphic density [21–23], potentially due to different mea-
surements and distributions of mammographic density and
air pollution. In Denmark [22], the authors found a weak
inverse association between having mixed/dense breasts
and residential exposure to nitrogen oxide that did not dif-
fer by menopausal status, but did not assess PM or con-
tinuous measures of mammographic density. In the Dutch
study of primarily postmenopausal women [21], there were
small positive associations observed between continuous
percent mammographic density and residential nitrogen
dioxide and PM2.5 absorbance but null associations for
small increases in PM2.5, PM2.5–10, and PM10 exposures. In
the five registries in the US-based Breast Cancer Surveil-
lance Consortium [23], PM2.5 at the participants’ zip code
was positively associated with categorical measures of
mammographic density based on the American College of
Radiology’s Breast Imaging-Reporting and Data System
(BI-RADS) categories. In addition to the methodologic dif-
ferences in measurement of mammographic density and
air pollution across previous studies, the inconsistent find-
ings suggest that geospatial variation in air pollution com-
position may account for the different findings in
Table 3 Estimated differencesa (95% confidence interval) in square-root-transformed percent mammographic density by distance to
roadways.
n Premenopausal p for region
interaction term
n Postmenopausal p for region
interaction term
Distance to A1 roads
≥ 200 meters 1576 Referent 0.95 1598 Referent 0.001
< 200 meters 47 –0.25 (–0.65, 0.15) 36 0.10 (–0.39, 0.60)
p value 0.22 0.68
Distance to A1–A2 roads 0.90 0.48
≥ 200 meters 1500 Referent 1510 Referent
50–199 meters 87 –0.13 (–0.43, 0.16) 84 –0.03 (–0.35, 0.30)
< 50 meters 36 0.06 (–0.39, 0.51) 40 –0.12 (–0.59, 0.35)
p trend 0.65 0.88
Distance to A1–A3 roads 0.43 0.47
≥ 200 meters 978 Referent 936 Referent
50–199 meters 413 –0.05 (–0.21, 0.11) 431 –0.16 (–0.33, 0.01)
< 50 meters 232 0.03 (–0.17, 0.23) 267 –0.11 (–0.31, 0.10)
p trend 0.73 0.17
aAdjusted for cohort, age at mammogram, body mass index at mammogram, parity and age at first birth categories, hormonal therapy use, history of biopsy-
confirmed benign breast disease, and date of mammogram
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Denmark, the Netherlands, and the United States. In the
current study, we observed regional differences among
postmenopausal women with positive associations between
PM2.5 and mammographic density in the Northeastern
United States, but null findings between PM2.5 and mam-
mographic density in the Midwest, South, and West. Re-
gional differences have also been noted in cardiovascular
disease outcomes, with stronger associations with PM2.5 in
the Northeast [35]. This may be in part due to the differ-
ences in PM2.5 levels, composition, and sources across re-
gions in the United States.
Fine particles (PM2.5) are primarily from combustion
sources, organic compounds, and metals that can pene-
trate the small airways and alveoli deep in the lung [31]
and have an atmospheric half-life ranging from days to
weeks [36]. In the United States, approximately 80% of
PM2.5 composition consists of sulfates, nitrates, ammo-
nium, elemental carbon, organic carbon, Na+, and silicon
and the remaining ~ 20% is a catch-all category consist-
ing largely of many minerals and metals (e.g., Pb, Cd, V,
Ni, Cu, Zn, Mn, and Fe); however, the distribution of
these major components differs across the United States
[36, 37]. In the Eastern United States, the proportions of
sulfate, ammonium, and the catch-all category for other
constituents were higher than in the Western United
States, with larger differences in summer, whereas PM2.5
composition in the Western United States was higher in
organic carbon, elemental carbon, nitrates, and silicon
[36, 37]. Furthermore, PM2.5 levels were highest in the
Eastern United States [36, 37], particularly in the North-
east [37]. The EPA describes in detail the formation,
composition, and sources of PM2.5 and PM2.5–10 [36].
The biological effects of exposure to PM appear to go
beyond the lung inducing systemic inflammation, oxida-
tive stress, and epigenetic changes seen with alterations
in circulating C-reactive protein, fibrinogen, white blood
cell counts, tumor necrosis factor alpha, interleukin-6,
DNA adducts, protein, lipids and DNA oxidation [38],
and DNA methylation [39, 40]. Taken together, the
higher levels and more heterogeneous composition of
PM2.5 in the Northeast than in other regions as well as
the half-life and biological plausibility of PM2.5 to induce
systemic changes may be germane to variation in breast
tissue composition seen only with PM2.5 among post-
menopausal women residing in the Northeast. Future
studies of PM and postmenopausal breast cancer risk
should be aware of the differences in PM composition
across regions of the United States.
While we observed largely null PM2.5–10 associations,
the inverse associations between coarse PM2.5–10 and
percent mammographic density among postmenopausal
women in the West were surprising, were lacking in bio-
logical plausibility, and were likely due to the greater un-
certainty inherent in the PM2.5–10 measurements or
chance. PM2.5–10 is formed by the break-up of large
solids and droplets (e.g., crushing, grinding and abrasion
of surfaces, dust suspension, and the evaporation of
ocean sprays) and is largely composed of soil, street dust,
fly ash from uncontrolled combustion, nitrates, sulfates,
crustal oxides (Si, Al, and Fe), sea salt, pollen, fungal
spores, insect fragments, other bioaerosols, and automo-
bile debris. The atmospheric half-life of PM2.5–10 is
shorter than that of PM2.5 ranging from minutes to
hours and PM2.5–10 can penetrate the extrathoracic and
upper tracheobronchial regions [36]. Compared to the
PM2.5 measurement estimations, coarse PM2.5–10 esti-
mates had lower cross-validation R2 coefficients across
all US regions (PM2.5 R
2 = 0.77 versus PM2.5–10 R
2 =
0.46) and within regions (PM2.5 in Southwest R
2 = 0.77,
Northwest R2 = 0.56, Northeast R2 = 0.72 versus PM2.5–10
in Southwest R2 = 0.53, Northwest R2 = 0.54, Northeast
R2 = 0.32), which suggests that PM2.5–10 estimates had
more error on average than PM2.5 estimates [33].
There are several limitations and strengths of the study.
Exposure measurement error is often a challenge. Several
types of error can contribute to measurement error of PM.
Instead of collecting personal exposure data that are not
feasible on a large epidemiologic scale, we used predictions
from spatio-temporal modeling. These data are subject to
both Berkson error, which results in imprecision, and clas-
sical error that usually results in attenuated estimates to-
ward the null [41, 42]. A combination of these errors could
be the reason for the largely null findings. Furthermore,
PM has many constituents [43, 44] and while the complex
mixture of constituents was largely not associated with
mammographic density, one cannot rule out that certain
constituents may have an effect that was not captured by
our measures of PM. While we did observe suggestive sub-
group findings among postmenopausal women, it is pos-
sible that chance may explain the subgroup findings.
Another limitation of the study’s exposure assessment is
the inability to incorporate time spent at the residence or
the time spent exposed to outdoor air pollution at the resi-
dence, and data on other ambient air pollutants such as
NOx/NO2 were not available in these cohorts. In this study,
we used spatio-temporal PM modeling that can reduce
classical error; this technique has been reported to be more
strongly correlated with personal PM exposure than using
PM values from a nearest monitor [41]. Lastly, we were
able to investigate the relationship of recent PM exposures;
however, recent environmental exposures may not be the
most relevant time window of exposure as research is
pointing to the importance of early life exposures around
the time of puberty and a woman’s first birth [45–48]. In
spite of the limitations inherent in the exposure assessment,
the strengths of the study included using a model of PM es-
timates that have been associated with other health condi-
tions in this cohort, including mortality, cardiovascular
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disease, lung cancer, hypertension, pulmonary embolism,
and cognitive decline [30, 49–54]. Furthermore, the study
was conducted among women residing across the conter-
minous United States, making it the most geographically
expansive study of mammographic density and air pollution
to date. The large size of the study allowed for stratified
analyses to explore the associations separately for premeno-
pausal and postmenopausal women and to assess regional
variations in the associations of PM and mammographic
density. Lastly, many of the known predictors of mammo-
graphic density were considered to control for potential
confounding.
Conclusions
This study does not provide evidence that PM in the
United States is associated with breast density variation.
However, there is suggestive evidence that fine PM in
the Northeast United States may influence breast tissue
composition for postmenopausal women. Furthermore,
this study cannot rule out the potential relationship of
PM exposures during earlier time windows of exposure
and mammographic density.
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